Pinned Tweet
Summit II is this weekend in Kobe.
Aubrey de Grey, Marian Goodell, Prof. Masataka Watanabe, Mac Davis, Rob Claar, Irit Rappley, Julie Ying Baron, Matt Scholz.
Demo Day Monday. 24–26 Oct. miraitech.city
3 days to Demo Day. 26 October at Orbis Hall, Kobe Fashion Museum. See what the next generation of longevity and biotech looks like: Tickets: miraitech.city
Summit II starts tomorrow in Kobe.
Sunday: Prof. Masataka Watanabe on "Digital Immortality via Seamless Mind Uploading and AI Replacement of Damaged Brain Circuitry".
Last tickets: miraitech.city
2 days to Summit II: From East to West, Bridging the Longevity Gap, 24–25 October in Kobe. Tickets: miraitech.city
Day 1 of Summit I. Thank you to our Saturday speakers @HayanoMotoshi @EleanorSheekey @bluemoon_yuichi @felix_oen @HeckerLouise @FoodLiesOrg @DeryaTR_ @abeyoando_jp @Muse_Bio @shojinmeat @ss_f_official @RIKEN_BDR @KobeU_Global
Summit II: 24 to 26 Oct. miraitech.city
What’s on the line at Demo Day. 🏆
On Monday 26 October at Orbis Hall in Kobe, the companies building through Mirai Tech City pitch for these awards:
Come and see who takes them home 👇 miraitech.city/
#MiraiTechCity #DemoDay #Startups #Longevity #Biotech #Kobe #Japan
Summit II, Day 2. Sunday 25 October, Kobe.
@bettslacroix @watanabemasata @mariangoodell @longevion @patrissimo @toddjapan @EleanorSheekey @danburonline @realNathanCheng @PedroHenriched @GraniteBio @thatmre @MinicircleDNA
Registration closes Fri 23 Oct. miraitech.city
Mirai Tech City wouldn’t be possible without the partners backing longevity, biotech and medtech in Kobe this October.
👇 miraitech.city/
#MiraiTechCity #Longevity #Biotech #Medtech #Kobe #Japan
Summit II, Day 1. Saturday 24 October, Kobe.
@aubreydegrey @cordeiro @adamgries @rieglobe @okw @julieyingbaron @OisinBio @AntlerJapan @LongevityEVF
Registration closes Fri 23 Oct. miraitech.city
What can the oldest humans alive teach us about ageing?
Natalie S. Coles de Grey (LEV Foundation): "Research and prospects of supercentenarian data"
Summit II, Sat 24 Oct, Kobe. miraitech.city
Day 2 of Summit I in Kobe. Thank you to our Sunday speakers @thatmre @devsodhi @j_n_justice @TaylorCapito @MinicircleDNA @AMED_officialGL @xprize @KobeU_Global
Summit II and Demo Day: 24 to 26 Oct. miraitech.city
Sat 24 Oct. Aubrey de Grey opens Summit II in Kobe:
"RMR1 was a qualified win: what combining four rejuvenation therapies did, and what RMR2 does next"
miraitech.city
Japan’s national insurance covers 70–90% of healthcare costs, with a monthly cap on patient payments. Market structure matters as much as science.
In Japan, eligible regenerative-medicine products can reach a self-pay market after Phase 1 safety data. If you have safety data and no clear revenue path, look again.
A therapy built for one patient’s mutation cannot run a thousand-patient trial. Japan’s N-of-1 ecosystem offers another route. If you’re building personalised medicine, this is the market to understand: miraitech.city/startups/
Most accelerators help you build a demo. Mirai helps you get pitch-ready, define growth strategy, access Japan’s pathways and meet capital. A demo is not a business.
Whether you’re at ideation, pre-seed or seed, Mirai is built to help you turn frontier science into a sharper company, a clearer growth strategy and a route to market.
Seven years on market while the trial runs. That is what conditional approval can buy a cell or gene therapy. Few countries move that fast. Tickets: miraitech.city
Japan’s regenerative-medicine pathway can be dramatically faster and cheaper than the standard Phase 3 route for eligible companies. If you’re building in biotech, understand the pathway.
Mirai Tech City retweeted
Kobe Biomedical Innovation Cluster is the partner here. They were responsible for supporting the first autologous cell therapy to fix macular degeneration. We recently toured another facility here that regrows teeth! So cool to hear all the stuff being developed. @miraitechcity


































